What is R&G PharmaStudies Co Price-to-Operating-Cash-Flow?
As of today (2024-05-13), R&G PharmaStudies Co's share price is ¥45.76.
R&G PharmaStudies Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2.21. Hence, R&G PharmaStudies Co's Price-to-Operating-Cash-Flow Ratio for today is 20.74.
The historical rank and industry rank for R&G PharmaStudies Co's Price-to-Operating-Cash-Flow or its related term are showing as below:
SZSE:301333'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 17.4 Med: 30.31 Max: 51.74
Current: 20.74
During the past 10 years, R&G PharmaStudies Co's highest Price-to-Operating-Cash-Flow Ratio was 51.74. The lowest was 17.40. And the median was 30.31.
R&G PharmaStudies Co's Cash Flow from Operations per share for the
three
months ended in Mar. 2024 was ¥0.24.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2.21.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of R&G PharmaStudies Co was 8.90% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 59.20% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 10.10% per year.
During the past 10 years, R&G PharmaStudies Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 80.70% per year. The lowest was -17.40% per year. And the median was 3.30% per year.
R&G PharmaStudies Co Price-to-Operating-Cash-Flow Historical Data
The historical data trend for R&G PharmaStudies Co's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
R&G PharmaStudies Co Price-to-Operating-Cash-Flow Chart
|
R&G PharmaStudies Co Annual Data
|
|
Trend |
Dec13 |
Dec14 |
Dec15 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
- |
- |
- |
32.43 |
26.17 |
|
R&G PharmaStudies Co Quarterly Data
|
|
Dec17 |
Dec18 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
34.64 |
36.56 |
34.78 |
26.17 |
22.83 |
Competitive Comparison of R&G PharmaStudies Co's Price-to-Operating-Cash-Flow
For the Biotechnology subindustry, R&G PharmaStudies Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
R&G PharmaStudies Co's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, R&G PharmaStudies Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where R&G PharmaStudies Co's Price-to-Operating-Cash-Flow falls into.
R&G PharmaStudies Co Price-to-Operating-Cash-Flow Calculation
R&G PharmaStudies Co's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 45.76 | / | 2.206 |
| = | 20.74 |
R&G PharmaStudies Co's Share Price of today is ¥45.76.
R&G PharmaStudies Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2.21.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
R&G PharmaStudies Co (SZSE:301333) Business Description
Traded in Other Exchanges
N/A
Address
No. 518, Chuangyi West Road, East District, Economic Development Zone, Tongzhou District, Beijing, CHN, 100048
R&G PharmaStudies Co Ltd is a clinical trial outsourcing service provider. It offers full-chain clinical research outsourcing services, serving global pharmaceutical and medical device companies and scientific research institutions.
R&G PharmaStudies Co (SZSE:301333) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:301333 has been successfully added to your